))
Biotech Insights: MIT’s Robert Langer on Startups & mRNA Innovation
Manage episode 434336701 series 3417662
コンテンツは joe@startuprad.io によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、joe@startuprad.io またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
In this episode of Startuprad.io, host Joe Menninger sits down with Professor Robert S. Langer, a renowned biotechnologist from MIT. Professor Langer, co-founder of Moderna and holder of over 1,400 patents, shares his expertise on biotech startups, innovation, and the future of mRNA technology.
Explore the critical differences between biotech sectors in Europe and the US, the key factors for biotech startup success, and the importance of great science, intellectual property, and business acumen. Professor Langer also discusses the essential role of government and private sector partnerships in fostering biotech innovation.
Discover insights on:
Biotech landscapes in Europe vs. the US
Success factors for biotech startups
Future of mRNA technology
Government and private sector partnerships
Diversity in research and its benefits
Funding challenges for biotech startups
Advancements in drug delivery systems
Memorable Quotes:
"Great science and intellectual property are the cornerstones of biotech success."
"Diversity in research teams leads to innovative outcomes."
Enjoyed this episode? Leave a review and share it with your network! Subscribe to our podcast for more expert interviews and insights. Join our vibrant community of tech entrepreneurs and stay updated with the latest in biotech innovation.
Links:
Original Blog Post: https://www.startuprad.io/blog
Work with us: https://www.startuprad.io/become-a-partner
Subscribe: https://linktr.ee/startupradio
#Biotech #Startup #Innovation #mRNA #RobertLanger #MIT #ModernMedicine #TechEntrepreneurship #Startupradio #Podcast
273 つのエピソード
シェア
